Biotech News

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Sotera Health (SHC)Sotera HealthEarnings

Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis (1) compared to Q2 2025 Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025 Q2 2026 Adjusted EBITDA ( 1) increased 10.0%, or 8.7% on a

Related news

Sotera Health

Healthcare Sterilization Infrastructure Sotera Health provides sterilization, laboratory testing and advisory services that support the safety and regulatory compliance of medical devices, pharmaceuticals and other healthcare products. Its businesses operate at critical points between product manufacturing and release to...

Recent company news

Stock data

Close
18.91 USD
Market cap
4.28B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States